Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
![Alex Azar](https://www.radiohc.cu/articles/3471-alex-azar-secretary.jpeg)
Related Articles
Commentaries
MAKE A COMMENT
All fields requiredMore Views
- Colombia, looking at the pension law from the point of view of love
- International Court of Justice at The Hague rules that Israeli occupation of Palestinian territory is unlawful
- UNESCO calls for Cuba's removal from the list of sponsors of terrorism
- Nicolás Maduro warned of possible civil war in Venezuela
- Mexican foreign minister highlights positive moment in U.S.-Mexico relations